Senti Biosciences, Inc. (SNTI) — Financial statements
Income statement, balance sheet, and cash flow for Senti Biosciences, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.02 | 0.00↓100.0% | 2↓39.8% | 3↑43.4% | 2 | |
| Cost of Revenue | 4 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | -4 | 0.00↓100.0% | 2↓39.8% | 3↑43.4% | 2 | |
| Operating Expenses | ||||||
| R&D Expenses | 38↑9.4% | 34↑6.9% | 32↑14.2% | 28↑28.2% | 22 | |
| General & Administrative Expenses | 26↑11.3% | 24↓32.6% | 35↓7.3% | 38↑77.1% | 21 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 26↑11.3% | 24↓32.6% | 35↓7.3% | 38↑77.1% | 21 | |
| Other Expenses | -4↓214.6% | 3↓88.5% | 28↑6886.0% | -0.41↑13.2% | -0.47 | |
| Operating Expenses | 60↓1.5% | 61↓35.5% | 95↑44.9% | 65↑53.0% | 43 | |
| Total Costs & Expenses | 64↑4.4% | 61↓35.5% | 95↑44.9% | 65↑53.0% | 43 | |
| Operating Results | ||||||
| Operating Income | -64↓4.4% | -61↑34.2% | -93↓49.4% | -62↓53.5% | -40 | |
| Depreciation & Amortization | 4↓37.8% | 6↑7.8% | 5↑38.5% | 4↑30.2% | 3 | |
| EBITDA | -60↓9.5% | -55↑10.5% | -61↓5.5% | -58↓55.4% | -37 | |
| EBIT | -64↓4.9% | -61↑9.0% | -67↓7.5% | -62↓53.5% | -40 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.93 | 0.00↓100.0% | 3↑68.4% | 2↑15363.6% | 0.01 | |
| Interest Income | 0.93 | 0.00↓100.0% | 3↑68.4% | 2↑15363.6% | 0.01 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -0.31↑98.8% | -26 | 0.00 | 0.00 | |
| Other Income / Expenses | 2↓72.3% | 8↓11.5% | 9↓24.9% | 12↑183.5% | -15 | |
| Income Before Tax | -61↓16.4% | -53↑36.7% | -83↓67.9% | -50↑10.2% | -55 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -61↓16.4% | -53↑36.7% | -83↓67.9% | -50↑10.2% | -55 | |
| Net Income from Discontinued Operations | 0.00 | 0.00↓100.0% | 12↑244.5% | -9 | 0.00 | |
| Net Income | -61↓16.4% | -53↑25.7% | -71↓22.1% | -58↓5.2% | -55 | |
| Bottom-Line Net Income | -61↓16.4% | -53↑25.7% | -71↓22.1% | -58↓5.2% | -55 | |
| EPS (Basic) | -2.73↑76.2% | -11.49↑45.1% | -20.94↓58.0% | -13.25↓4.6% | -12.67 | |
| EPS (Diluted) | -2.73↑76.2% | -11.49↑45.1% | -20.94↓58.0% | -13.25↓4.6% | -12.67 | |
| Weighted Average Shares | 225↑4791.9% | 5↑3.6% | 4↑1.0% | 4↑0.7% | 4 | |
| Weighted Average Diluted Shares | 225↑4791.9% | 5↑3.6% | 4↑1.0% | 4↑0.7% | 4 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.